The phase 3 COSMOS study evaluated the efficacy and safety of guselkumab in 285 adults with active PsA who had an inadequate response to anti-tumor necrosis factors.
Investigators assessed whether the increase in early-onset colorectal cancer incidence is a product of increased colonoscopy screening or due to other factors.
The safety and feasibility of treating patients with infantile hemangiomas with a combination of pulsed-dye laser (PDL) and 0.5% timolol maleate solution is investigated.
In an update to treatment strategies for motor symptoms in early Parkinson disease, the American Academy of Neurology has reviewed the research on the benefits and risks of available medications.
The sNDA submission is supported by data from a phase 3 trial that compared the efficacy and safety of fenfluramine with placebo in 263 patients aged 2 to 35 years with LGS.
Investigators assessed the association between diet quality and risk for and severity of COVID-19, as well as its relationship with socioeconomic deprivation.
Using the Mayo Clinic’s COVID-19 Vaccine Registry, researchers were able to measure the incidence of myocarditis after patients received COVID-19 mRNA vaccination.
